| |
Peptide Modification Scope and Price
Special amino acid
|
|
|
|
D-Arg, D-Asp, D-Asn,D-Cys, D-Glu, D-Gln, D-His, D-Ile, D-Lys, D-Ser, D-Thr, D-Trp, D-Tyr, D-Orn,
|
|
|
|
|
D-Ala, D-Leu, D-Met, D-Pro, D-Val, D-Phe
|
|
|
|
Beta-Ala, pGlu, Hyp
|
|
|
|
N-Methyl amino acid (Ala, Gly, Ile, Leu, Met, Phe, Val)
|
|
|
|
|
|
|
|
|
Dinitrobenzoylation (Lys)
|
|
|
|
|
|
|
|
|
Phosphorylation (Ser, Thr, Tyr, single site)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_________________________________________________________________________________________________________
Fluorescence/Dye labeling
|
|
|
|
Biotin (N-Terminal, Y/N Ahx)
|
|
|
|
|
Biotin (Lys in sequence)
|
|
|
|
Biotin (without Lys in sequence)
|
|
|
|
Dansyl (N-Terminal, Y/N Ahx)
|
|
|
|
|
|
|
|
|
FITC/5-FAM (N-Terminal, Y/N Ahx)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benzyloxycarbonylation (CBz)
|
|
|
|
|
|
|
|
|
Me, Et or Bzl (C-Terminal)
|
|
|
|
|
|
|
|
|
|
|
|
|
Myristic acid (N-Terminal)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
p-Nitroanilide (pNA, C-Terminal)
|
|
|
|
|
|
|
|
|
Succinylation (Suc, N-Terminal)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTEGRATED SERVICE PLATFORM
Quenched fluorescent peptide
|
|
|
|
|
|
|
|
Asp (EDANS), Glu (EDANS)
|
|
|
|
EDANS or DABCYL
|
|
|
|
|
CUSTOM PEPTIDE CORE TECHNOLOGY
Multiple Antigenic Peptide System
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KLH
|
|
|
|
|
Cyclic peptide
|
|
|
|
|
|
|
|
|
|
|
|
Amide cyclic (Side chain, end)
|
|
|
|
|
|
CATALOG PEPTIDES
Alphabetical Search for Catalog Peptides
|
Copyright © 2009 - 2016 ACES Pharma Inc. All rights reserved.
|
Our antigen peptides allow the creation of peptide antibodies in animals without the need of purifying the protein of interest. This involves synthesizing antigenic peptides of sections of the protein of interest. These will then be used to make antibodies in a rabbit or mouse against the protein.
ACES PHARMA building blocks of life
Custom Peptides
|